COVID-19 Disruptions to Elective Postoperative Care Did Not Adversely Affect Early Complications or Patient Reported Outcomes of Primary TKA
Overview
General Surgery
Orthopedics
Authors
Affiliations
Introduction: Elective orthopedic care, including in-person office visits and physical therapy (PT), was halted on March 16, 2020, at a large, urban hospital at the onset of the local COVID-19 surge. Post-discharge care was provided predominantly through a virtual format. The purpose of this study was to assess the impact of postoperative care disruptions on early total knee arthroplasty (TKA) outcomes, specifically 90-day complications, 120-day rate of manipulation under anesthesia (MUA) and 1-year patient-reported outcome measures (PROMs).
Materials And Methods: Institutional records were queried to identify 624 patients who underwent primary, unilateral TKA for osteoarthritis and who were discharged home between 1/1/20 and 3/15/20. These patients were compared to 558 controls discharged between 1/1/19 and 3/15/2019. Cohort demographics and in-hospital characteristics were equivalent apart from inpatient morphine milligram equivalent (MME) consumption. Patient-reported access to PT (p < 0.001) and post-discharge care (p < 0.001) were worse among study patients. Study patients were prescribed fewer post-discharge PT sessions (19.8 vs. 23.5; p < 0.001) and utilized telehealth more frequently (p < 0.001). Mann-Whitney U, T, Fisher's Exact, and chi-squared tests were used to compare outcomes.
Results: Ninety-day CMS complications were lower among study patients (3.5% vs. 5.9%; p = 0.05). Rates of MUA were similar between groups. Study patients reported similar PROMs and marginally inferior VR-12 mental and LEAS functional outcomes at 1 year.
Conclusion: Disruptions to elective orthopedic care in March 2020 seemed to have had no major consequences on clinical outcomes for TKA patients. Our findings question the usefulness of pre-pandemic post-discharge protocols, which may over-emphasize in-person visits and PT.
Challenges with patient management of osteoarthritis during the COVID-19 pandemic: review.
Patel T, Coiado O Ann Med Surg (Lond). 2023; 85(8):3925-3930.
PMID: 37554908 PMC: 10406077. DOI: 10.1097/MS9.0000000000000978.
Bae J, Seo J, Shin S, Kim S, Kim J J Clin Med. 2023; 12(13).
PMID: 37445528 PMC: 10342263. DOI: 10.3390/jcm12134496.
Identification of 3 key genes as novel diagnostic and therapeutic targets for OA and COVID-19.
Zhang Y, Duan Z, Guan Y, Xu T, Fu Y, Li G Front Immunol. 2023; 14:1167639.
PMID: 37283761 PMC: 10239847. DOI: 10.3389/fimmu.2023.1167639.
Mirghaderi S, Salimi M, Moharrami A, Hosseini-Dolama R, Mirghaderi S, Ghaderi M Arthroplast Today. 2022; 18:76-83.
PMID: 36185411 PMC: 9513341. DOI: 10.1016/j.artd.2022.09.005.